PLCB3 and atherosclerosis: Pathway analysis indicated that PLCB3 is associated with lipid and atherosclerosis pathways, the NOD-like receptor signaling pathway, and the NF-κB signaling pathway, all of which are essential for recognizing pathogens and initiating inflammatory responses [39].